A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Dendritic cells are rare haematopoietic cells that reside in a number of organs and tissues. By capturing, processing and presenting antigens to T cells, dendritic cells are essential for immune surveillance and the regulation of specific immunity. Several members of the tumour necrosis factor receptor (TNFR) superfamily are integral to the regulation of the immune response. These structurally related proteins modulate cellular functions ranging from proliferation and differentiation to inflammation and cell survival or deaths. The functional activity of dendritic cells is greatly increased by signalling through the TNFR family member CD40. Here we report the characterization of RANK (for receptor activator of NF-kappaB), a new member of the TNFR family derived from dendritic cells, and the isolation of a RANK ligand (RANKL) by direct expression screening. RANKL augments the ability of dendritic cells to stimulate naive T-cell proliferation in a mixed lymphocyte reaction, and increases the survival of RANK+ T cells generated with interleukin-4 and transforming growth factor (TGF)-beta. Thus RANK and RANKL seem to be important regulators of interactions between T cells and dendritic cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The receptor that mediates all known activities for RANKL is called receptor activator of nuclear factor B (RANK) (Figs. 1 and 2).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [41]
Citations
Cites
Basic local alignment search tool
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990) · Journal of Molecular Biology · doi:10.1006/jmbi.1990.9999 · Cited by 98,669
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
The Dendritic Cell System and its Role in Immunogenicity
Steinman, R. M. (1991) · Annual Review of Immunology · doi:10.1146/annurev.iy.09.040191.001415 · Cited by 4,658
Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A., & Alber, G. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.747 · Cited by 1,983
The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death
Smith, C. A., Farrah, T., & Goodwin, R. G. (1994) · Cell · doi:10.1016/0092-8674(94)90372-7 · Cited by 1,887
Activation of human dendritic cells through CD40 cross-linking.
Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, I., & Banchereau, J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1263 · Cited by 1,317
TRAF2-Mediated Activation of NF-κB by TNF Receptor 2 and CD40
Rothe, M., Sarma, V., Dixit, V. M., & Goeddel, D. V. (1995) · Science · doi:10.1126/science.7544915 · Cited by 1,051
Wong, B. R., Rho, J., Arron, J., Robinson, E., Orlinick, J., Chao, M., Kalachikov, S., Cayani, E., Bartlett, F. S., Frankel, W. N., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25190 · Cited by 1,042
Molecular and biological characterization of a murine ligand for CD40
Armitage, R. J., Fanslow, W. C., Strockbine, L., Sato, T. A., Clifford, K. N., Macduff, B. M., Anderson, D. M., Gimpel, S. D., Davis-Smith, T., Maliszewski, C. R., et al. (1992) · Nature · doi:10.1038/357080a0 · Cited by 1,022
Self-citationHerpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor
Yao, Z., Fanslow, W. C., Seldin, M. F., Rousseau, A.-M., Painter, S. L., Comeau, M. R., Cohen, J. I., & Spriggs, M. K. (1995) · Immunity · doi:10.1016/1074-7613(95)90070-5 · Cited by 994
Cited by
Items 201–300 of 1,012
Bachmann, M. F., Wong, B. R., Josien, R., Steinman, R. M., Oxenius, A., & Choi, Y. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.7.1025 · Cited by 260
Pasco, J. A., Henry, M. J., Sanders, K. M., Kotowicz, M. A., Seeman, E., & Nicholson, G. C. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301214 · Cited by 260
Huang, L., Xu, J., Wood, D. J., & Zheng, M. H. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64942-5 · Cited by 260
TNF.ALPHA. and pathologic bone resorption
Boyce, B. E., Li, P., Yao, Z., Zhang, Q., Badell, I. R., Schwarz, E. M., O’Keefe, R. J., & Xing, L. (2005) · The Keio Journal of Medicine · doi:10.2302/kjm.54.127 · Cited by 259
Weitzmann, M. N. (2013) · Scientifica · doi:10.1155/2013/125705 · Cited by 259
RANK ligand and osteoprotegerin in myeloma bone disease.
Sezer, O., Heider, U., Zavrski, I., Kühne, C. A., & Hofbauer, L. C. (2003) · Blood · doi:10.1182/blood-2002-09-2684 · Cited by 258
Shipman, C. M., & Croucher, P. I. (2003) · PubMed · Cited by 258
Kikuchi, T., Matsuguchi, T., Tsuboi, N., Mitani, A., Tanaka, S., Matsuoka, M., Yamamoto, G., Hishikawa, T., Noguchi, T., & Yoshikai, Y. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.5.3574 · Cited by 255
Kiechl, S., Wittmann, J., Giaccari, A., Knoflach, M., Willeit, P., Bozec, A., Moschen, A. R., Muscogiuri, G., Sorice, G. P., Kireva, T., et al. (2013) · Nature Medicine · doi:10.1038/nm.3084 · Cited by 255
Zhang, G., Qin, L., & Shi, Y. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070405 · Cited by 255
Tumor Necrosis Factor-α Supports the Survival of Osteoclasts through the Activation of Akt and ERK
Lee, S. E., Chung, W. J., Kwak, H. B., Chung, C.-H., Kwack, K., Lee, Z. H., & Kim, H.-H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103642200 · Cited by 254
Osteoclasts and giant cells: macrophage–macrophage fusion mechanism
Vignery, A. (2000) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2000.00164.x · Cited by 254
Clines, G. A., & Guise, T. A. (2005) · Endocrine-Related Cancer · doi:10.1677/erc.1.00543 · Cited by 253
Breuil, V., Schmid‐Antomarchi, H., Schmid‐Alliana, A., Rezzonico, R., Euller‐Ziegler, L., & Rossi, B. (2003) · The FASEB Journal · doi:10.1096/fj.02-1188fje · Cited by 253
Ruocco, M. G., Maeda, S., Park, J. M., Lawrence, T., Hsu, L.-C., Cao, Y., Schett, G., Wagner, E. F., & Karin, M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042081 · Cited by 252
Takeshita, S., Namba, N., Zhao, J. J., Jiang, Y., Genant, H. K., Silva, M. J., Brodt, M. D., Helgason, C. D., Kalesnikoff, J., Rauh, M. J., et al. (2002) · Nature Medicine · doi:10.1038/nm752 · Cited by 252
The Actions and Interactions of Sex Steroids and Growth Factors/Cytokines on the Skeleton
Spelsberg, T. C. (1999) · Molecular Endocrinology · doi:10.1210/me.13.6.819 · Cited by 251
Itoh, K., Udagawa, N., Katagiri, T., Iemura, S., Ueno, N., Yasuda, H., Higashio, K., Quinn, J. M. W., Gillespie, M. T., Martin, T. J., et al. (2001) · Endocrinology · doi:10.1210/endo.142.8.8300 · Cited by 250
Suda, T., Ueno, Y., Fujii, K., & Shinki, T. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10331 · Cited by 250
Armstrong, A. P., Tometsko, M. E., Glaccum, M., Sutherland, C. L., Cosman, D., & Dougall, W. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202009200 · Cited by 249
Self-citationPathogenesis of bone erosions in rheumatoid arthritis
Goldring, S. R., & Gravallese, E. M. (2000) · Current Opinion in Rheumatology · doi:10.1097/00002281-200005000-00006 · Cited by 249
Qiang, Y.-W., Chen, Y., Stephens, O., Brown, N., Chen, B., Epstein, J., Barlogie, B., & Shaughnessy, J. D. (2008) · Blood · doi:10.1182/blood-2008-01-132134 · Cited by 248
Vega, D., Maalouf, N. M., & Sakhaee, K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0646 · Cited by 246
Hirotani, H., Tuohy, N. A., Woo, J.-T., Stern, P. H., & Clipstone, N. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m213067200 · Cited by 246
Wu, Y., Bressette, D., Carrell, J. A., Kaufman, T., Feng, P., Taylor, K., Gan, Y., Cho, Y. H., Garcia, A. D., Gollatz, E., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005224200 · Cited by 245
Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells.
Standal, T., Seidel, C., Hjertner, Ø., Plesner, T., Sanderson, R. D., Waage, A., Borset, M., & Sundan, A. (2002) · Blood · doi:10.1182/blood-2002-04-1190 · Cited by 244
Physiological and pathophysiological bone turnover — role of the immune system
Weitzmann, M. N., & Ofotokun, I. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.91 · Cited by 240
Danks, L., Komatsu, N., Guerrini, M. M., Sawa, S., Armaka, M., Kollias, G., Nakashima, T., & Takayanagi, H. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-207137 · Cited by 240
Connection Between B Lymphocyte and Osteoclast Differentiation Pathways
Manabe, N., Kawaguchi, H., Chikuda, H., Miyaura, C., Inada, M., Nagai, R., Nabeshima, Y.-I., Nakamura, K., Sinclair, A. M., Scheuermann, R. H., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2625 · Cited by 240
Tsukii, K., Shima, N., Mochizuki, S.-I., Yamaguchi, K., Kinosaki, M., Yano, K., Shibata, O., Udagawa, N., Yasuda, H., Suda, T., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8610 · Cited by 238
Hikita, A., Yana, I., Wakeyama, H., Nakamura, M., Kadono, Y., Oshima, Y., Nakamura, K., Seiki, M., & Tanaka, S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606656200 · Cited by 236
Cell lines and primary cell cultures in the study of bone cell biology
Kartsogiannis, V., & Ng, K. W. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.06.002 · Cited by 236
Advances in osteoclast biology: old findings and new insights from mouse models
Edwards, J. R., & Mundy, G. R. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.23 · Cited by 235
Discovery of the RANKL/RANK/OPG system
Yasuda, H. (2021) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-020-01175-1 · Cited by 234
Heymann, M.-F., Lézot, F., & Heymann, D. (2019) · Cellular Immunology · doi:10.1016/j.cellimm.2017.10.011 · Cited by 233
TRANCE is a TNF family member that regulates dendritic cell and osteoclast function
Wong, B. R., Josien, R., & Choi, Y. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.65.6.715 · Cited by 232
Harrop, J. A., McDonnell, P. C., Brigham-Burke, M., Lyn, S. D., Minton, J., Tan, K. B., Dede, K., Spampanato, J., Silverman, C., Hensley, P., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.42.27548 · Cited by 232
NF-κB modulators in osteolytic bone diseases
Xu, J., Wu, H. F., Ang, E. S. M., Yip, K., Woloszyn, M., Zheng, M. H., & Tan, R. X. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.11.007 · Cited by 229
Lossdörfer, S., Schwartz, Z., Wang, L., Lohmann, C. H., Turner, J. D., Wieland, M., Cochran, D. L., & Boyan, B. D. (2004) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30025 · Cited by 228
Osteonecrosis of the jaws induced by anti-RANK ligand therapy
Taylor, K. H., Middlefell, L. S., & Mizen, K. D. (2010) · British Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.bjoms.2009.08.030 · Cited by 228
Tumour escape from immune surveillance through dendritic cell inactivation
Vicari, A. P., Caux, C., & Trinchieri, G. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0400 · Cited by 228
Fu, Q., Jilka, R. L., Manolagas, S. C., & O'Brien, C. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208494200 · Cited by 227
Kimonis, V. E., Fulchiero, E., Vesa, J., & Watts, G. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.09.003 · Cited by 227
Dysregulated Osteoprotegerin/RANK Ligand/RANK Axis in Clinical and Experimental Heart Failure
Ueland, T., Yndestad, A., Øie, E., Florholmen, G., Halvorsen, B., Frøland, S. S., Simonsen, S., Christensen, G., Gullestad, L., & Aukrust, P. (2005) · Circulation · doi:10.1161/01.cir.0000165119.62099.14 · Cited by 227
IL-1 plays an important role in the bone metabolism under physiological conditions
Lee, Y.-M., Fujikado, N., Manaka, H., Yasuda, H., & Iwakura, Y. (2010) · International Immunology · doi:10.1093/intimm/dxq431 · Cited by 226
The Macrophage-Osteoclast Axis in Osteoimmunity and Osteo-Related Diseases
Yao, Y., Cai, X., Ren, F., Ye, Y., Wang, F., Zheng, C., Qian, Y., & Zhang, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.664871 · Cited by 224
Kovács, B., Vajda, E., & Nagy, E. E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184653 · Cited by 224
Role of RANKL and RANK in bone loss and arthritis
Jones, D. H., Kong, Y.-Y., & Penninger, J. M. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.suppl_2.ii32 · Cited by 223
Osteoclasts, rheumatoid arthritis, and osteoimmunology
Sato, K., & Takayanagi, H. (2006) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000231912.24740.a5 · Cited by 223
Li, P., Schwarz, E. M., O'Keefe, R. J., Ma, L., Boyce, B. F., & Xing, L. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301233 · Cited by 220
Kashii, Y., Giorda, R., Herberman, R. B., Whiteside, T. L., & Vujanovic, N. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5358 · Cited by 220
RANKing Intracellular Signaling in Osteoclasts
Feng, X. (2005) · IUBMB Life (International Union of Biochemistry and Molecular Biology: Life) · doi:10.1080/15216540500137669 · Cited by 219
Motyckova, G., Weilbaecher, K. N., Horstmann, M., Rieman, D. J., Fisher, D. Z., & Fisher, D. E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091479298 · Cited by 219
HOROWITZ, M., XI, Y., WILSON, K., & KACENA, M. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00030-7 · Cited by 217
LIU, W., & ZHANG, X. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3152 · Cited by 216
Osteoimmunology: Crosstalk Between the Immune and Bone Systems
Nakashima, T., & Takayanagi, H. (2009) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9316-6 · Cited by 216
Ikeda, T., Kasai, M., Utsuyama, M., & Hirokawa, K. (2001) · Endocrinology · doi:10.1210/endo.142.4.8070 · Cited by 215
Potential role of the intestinal microbiota of the mother in neonatal immune education
Donnet-Hughes, A., Perez, P. F., Doré, J., Leclerc, M., Levenez, F., Benyacoub, J., Serrant, P., Segura-Roggero, I., & Schiffrin, E. J. (2010) · Proceedings of the Nutrition Society · doi:10.1017/s0029665110001898 · Cited by 215
Hofbauer, L. C., Neubauer, A., & Heufelder, A. E. (2001) · Cancer · doi:10.1002/1097-0142(20010801)92:3<460::aid-cncr1344>3.0.co;2-d · Cited by 215
CD1-dependent dendritic cell instruction
Vincent, M. S., Leslie, D. S., Gumperz, J. E., Xiong, X., Grant, E. P., & Brenner, M. B. (2002) · Nature Immunology · doi:10.1038/ni851 · Cited by 214
RANKL/OPG; Critical role in bone physiology
Martin, T. J., & Sims, N. A. (2015) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-014-9308-6 · Cited by 213
“signaling pathway arose from study of the T cell-dependent immune response [41].”
BackgroundTogari, A. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10121 · Cited by 213
Oral Inflammatory Diseases and Systemic Inflammation: Role of the Macrophage
Hasturk, H., Kantarci, A., & Van Dyke, T. E. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00118 · Cited by 212
Hofbauer, L. C., Shui, C., Riggs, B. L., Dunstan, C. R., Spelsberg, T. C., O'Brien, T., & Khosla, S. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4130 · Cited by 211
Osteoprotegerin diminishes advanced bone cancer pain.
Luger, N. M., Honoré, P., Sabino, M., Schwei, M. J., Rogers, S. D., Mach, D. B., Clohisy, D. R., & Mantyh, P. W. (2001) · PubMed · Cited by 211
B Cell Development and Maturation
Wang, Y., Liu, J., Burrows, P. D., & Wang, J.-Y. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-15-3532-1_1 · Cited by 210
Min, J.-K., Kim, Y.-M., Kim, S. W., Kwon, M.-C., Kong, Y.-Y., Hwang, I. K., Won, M. H., Rho, J., & Kwon, Y.-G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.531 · Cited by 210
Kim, M. S., Yang, Y.-M., Son, A., Tian, Y. S., Lee, S.-I., Kang, S. W., Muallem, S., & Shin, D. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.051557 · Cited by 208
Sedger, L. M., Glaccum, M. B., Schuh, J. C. L., Kanaly, S. T., Williamson, E., Kayagaki, N., Yun, T., Smolak, P. J., Le, T., Goodwin, R. G., et al. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200208)32:8<2246::aid-immu2246>3.0.co;2-6 · Cited by 208
Human osteoclasts derive from CD14‐positive monocytes
Massey, & Flanagan (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01491.x · Cited by 207
A Genome-Wide Association Study of Myasthenia Gravis
Renton, A. E., Pliner, H. A., Provenzano, C., Evoli, A., Ricciardi, R., Nalls, M. A., Marangi, G., Abramzon, Y., Arepalli, S., Chong, S., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2014.4103 · Cited by 206
Li, P., Schwarz, E. M., O'Keefe, R. J., Ma, L., Looney, R. J., Ritchlin, C. T., Boyce, B. F., & Xing, L. (2004) · Arthritis & Rheumatism · doi:10.1002/art.11419 · Cited by 205
Circulating Osteoprotegerin Levels and Long-Term Prognosis in Patients With Acute Coronary Syndromes
Omland, T., Ueland, T., Jansson, A. M., Persson, A., Karlsson, T., Smith, C., Herlitz, J., Aukrust, P., Hartford, M., & Caidahl, K. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.058 · Cited by 205
Cobbold, S., & Waldmann, H. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80217-3 · Cited by 203
Wooley, P., & Schwarz, E. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302202 · Cited by 203
Wei, S., Wang, M. W.-H., Teitelbaum, S. L., & Ross, F. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m104957200 · Cited by 202
Osteoimmunology and the influence of pro-inflammatory cytokines on osteoclasts
Zupan, J., Jeras, M., & Marc, J. (2013) · Biochemia Medica · doi:10.11613/bm.2013.007 · Cited by 202
TRAF‐Mediated TNFR‐Family Signaling
Ha, H., Han, D., & Choi, Y. (2009) · Current Protocols in Immunology · doi:10.1002/0471142735.im1109ds87 · Cited by 154
Walsh, M. C., & Choi, Y. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00027-3 · Cited by 200
CD1-mediated γ/δ T Cell Maturation of Dendritic Cells
Leslie, D. S., Vincent, M. S., Spada, F. M., Das, H., Sugita, M., Morita, C. T., & Brenner, M. B. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021515 · Cited by 200
A role for TGFβ1 in osteoclast differentiation and survival
Fuller, K., Lean, J. M., Bayley, K. E., Wani, M. R., & Chambers, T. J. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.13.2445 · Cited by 199
Palafox, M., Ferrer, I., Pellegrini, P., Vila, S., Hernandez-Ortega, S., Urruticoechea, A., Climent, F., Soler, M. T., Muñoz, P., Viñals, F., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0044 · Cited by 199
Self-citationThe Blimp1–Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis
Miyauchi, Y., Ninomiya, K., Miyamoto, H., Sakamoto, A., Iwasaki, R., Hoshi, H., Miyamoto, K., Hao, W., Yoshida, S., Morioka, H., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091957 · Cited by 199
Steinman, R. M., & Inaba, K. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.66.2.205 · Cited by 198
Kim, Y., Sato, K., Asagiri, M., Morita, I., Soma, K., & Takayanagi, H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505820200 · Cited by 198
Dougall, W. C. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2507 · Cited by 198
Self-citationReceptor-Mediated Choreography of Life and Death
Bhardwaj, A., & Aggarwal, B. B. (2003) · Journal of Clinical Immunology · doi:10.1023/a:1025319031417 · Cited by 198
Bortezomib inhibits human osteoclastogenesis
von Metzler, I., Krebbel, H., Hecht, M., Manz, R. A., Fleissner, C., Mieth, M., Kaiser, M., Jakob, C., Sterz, J., Kleeberg, L., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404806 · Cited by 197
Expression of Osteoclast Differentiation Signals by Stromal Elements of Giant Cell Tumors
Atkins, G. J., Haynes, D. R., Graves, S. E., Evdokiou, A., Hay, S., Bouralexis, S., & Findlay, D. M. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.4.640 · Cited by 197
Bone loss: Factors that regulate osteoclast differentiation - an update
Roux, S., & Orcel, P. (2000) · Arthritis Research & Therapy · doi:10.1186/ar127 · Cited by 196
Yun, T. J., Tallquist, M. D., Aicher, A., Rafferty, K. L., Marshall, A. J., Moon, J. J., Ewings, M. K., Mohaupt, M., Herring, S. W., & Clark, E. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.1482 · Cited by 195
“Because both RANK and OPG are expressed in B lineage cells (1, 13) and both are up-regulated by CD40 cross-linking, we next analyzed peripheral B cell populations.”
BackgroundInfluentialThe osteoprotegerin/RANK/RANKL system: a bone key to vascular disease
Kiechl, S., Werner, P., Knoflach, M., Furtner, M., Willeit, J., & Schett, G. (2006) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.4.6.801 · Cited by 195
Saika, M., Inoue, D., Kido, S., & Matsumoto, T. (2001) · Endocrinology · doi:10.1210/endo.142.6.8220 · Cited by 194
RANK, RANKL and osteoprotegerin in bone biology and disease
Wright, H. L., McCarthy, H. S., Middleton, J., & Marshall, M. J. (2009) · Current Reviews in Musculoskeletal Medicine · doi:10.1007/s12178-009-9046-7 · Cited by 194
Crystal structure of the TRANCE/RANKL cytokine reveals determinants of receptor-ligand specificity
Lam, J., Nelson, C. A., Ross, F. P., Teitelbaum, S. L., & Fremont, D. H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13890 · Cited by 194
Huang, J., Yuan, L., Wang, X., Zhang, T.-L., & Wang, K. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.07.015 · Cited by 194
Itoh, K., Udagawa, N., Kobayashi, K., Suda, K., Li, X., Takami, M., Okahashi, N., Nishihara, T., & Takahashi, N. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3688 · Cited by 194
Molecular mechanisms and clinical management of cancer bone metastasis
Wang, M., Xia, F., Wei, Y., & Wei, X. (2020) · Bone Research · doi:10.1038/s41413-020-00105-1 · Cited by 193
The advantages of co-culture over mono cell culture in simulating in vivo environment
Miki, Y., Ono, K., Hata, S., Suzuki, T., Kumamoto, H., & Sasano, H. (2012) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.12.004 · Cited by 192
The role of T lymphocytes in bone metabolism
Weitzmann, M. N., & Pacifici, R. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00324.x · Cited by 192
Metadata
- Authors
- Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L.
- Corresponding author
- Anderson, Dirk M.
- Venue
- Nature
- Published
- 1997-11
- Volume
- 390
- Issue
- 6656
- Pages
- 175-179
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1650001464
- Cited by
- 2,290
- References
- 30
- Citations by year
- 2026: 31 · 2025: 32 · 2024: 37 · 2023: 45 · 2022: 53 · 2021: 79 · 2020: 74 · 2019: 63 · 2018: 56 · 2017: 71 · 2016: 53 · 2015: 73 · 2014: 80 · 2013: 83 · 2012: 94
- FWCI
- 37.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- RANK, RANK ligand, TNF receptor superfamily, dendritic cells, T cell proliferation, T cell survival, antigen presentation, immune regulation, IL-4, TGF-beta, mixed lymphocyte reaction
- MeSH terms
- Amino Acid Sequence, Animals, Carrier Proteins, Cell Line, Cells, Cultured, Chromosome Mapping, Chromosomes, Human, Pair 13, Chromosomes, Human, Pair 18, Dendritic Cells, Humans, Ligands, Membrane Glycoproteins, Membrane Proteins, Molecular Sequence Data, T-Lymphocytes, Transfection, Sequence Homology, Amino Acid, Receptors, Tumor Necrosis Factor, CD40 Ligand, Mice, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.